Amrita Ahluwalia

Last updated
Amrita Ahluwalia
Amrita Ahluwalia on University of Oxford.jpg
Ahluwalia in 2020
Alma mater University of Bath
Queen Mary University of London
Scientific career
Institutions University College London
Queen Mary University of London
Thesis Investigations into the mechanisms of topical steroid anti-inflammatory action  (1993)
Academic advisors Patrick Vallance

Amrita Ahluwalia is a British pharmacologist and professor of vascular pharmacology at Queen Mary University of London. Her research considers the development of therapeutics for cardiovascular inflammation. She was awarded the WISE Research Award in 2015.

Contents

Early life and education

Ahluwalia studied pharmacology as an undergraduate at the University of Bath. During her undergraduate degree she spent a year at Glaxo, where the systems and efficiency impressed her. [1] [2] Here she explored drugs that looked to improve coronary vascular function, and was first introduced to animal dissection. [1] At Glaxo she also started using in vivo assays. [1] She was a doctoral researcher at the Queen Mary University of London William Harvey Research Institute, where she studied the mechanisms of anti-inflammatory actions of topical steroids. [3] After earning her doctorate she moved to St George's, University of London, where she worked with Patrick Vallance. [4] [5]

Research and career

Ahluwalia joined the faculty at the University College London, where she was part of the Cruciform Project that would become the Wolfson Institute for Biomedical Research. [2] She eventually returned to Queen Mary University of London, where she was made Professor of Pharmacology. Her early research focussed on the development of therapeutics for cardiovascular inflammation. She identified a new Nitric Oxide synthesis pathway, and found that beetroot could lower hypertension. [6]

In the early 2000s she started working on an endothelial mediator that required the generation of a knockout mouse, and, to maximise efficiency, used female as well as male mice in her clinical trials. [1] She showed that pharmaceuticals aimed at reducing blood pressure used a different biological pathway in female (as opposed to male) mice, which resulted in the release of different mediators. [1]

Today, Ahluwalia studies how sex differences impact drug action of cardiovascular disease. The majority of FDA-approved pharmaceuticals have adverse effects in women. [7] Her human studies have shown that women recover from inflammation quicker, which is why they are less susceptible to coronary disease. [1]

Academic service

In 2005 she established the British Pharmacological Society women's mentoring programme, and established the Women in Pharmacology Committee in 2007. She served as Director of the William Harvey Research Institute from 2013 to 2020. She is the current Director of the UK Clinical Research Collaboration Cardiovascular Clinical Trials Unit. She served as Editor-in-Chief of the British Journal of Pharmacology from 2016 to 2022. [1]

Awards and prizes

Select publications

Related Research Articles

Essential hypertension is a form of hypertension without an identifiable physiologic cause. It is the most common type affecting 85% of those with high blood pressure. The remaining 15% is accounted for by various causes of secondary hypertension. Essential hypertension tends to be familial and is likely to be the consequence of an interaction between environmental and genetic factors. Hypertension can increase the risk of cerebral, cardiac, and renal events.

<span class="mw-page-title-main">Lydia Rabinowitsch-Kempner</span> American bacteriologist and physician (1871–1935)

Lydia Rabinowitsch-Kempner was a Jewish bacteriologist and physician, known for her research on tuberculosis and public health. She was the second woman to become a Professor in Prussia.

Arterial stiffness occurs as a consequence of biological aging and arteriosclerosis. Inflammation plays a major role in arteriosclerosis development, and consequently it is a major contributor in large arteries stiffening. Increased arterial stiffness is associated with an increased risk of cardiovascular events such as myocardial infarction, hypertension, heart failure and stroke, the two leading causes of death in the developed world. The World Health Organization predicts that in 2010, cardiovascular disease will also be the leading killer in the developing world and represents a major global health problem.

<span class="mw-page-title-main">Thromboxane A2</span> Chemical compound

Thromboxane A2 (TXA2) is a type of thromboxane that is produced by activated platelets during hemostasis and has prothrombotic properties: it stimulates activation of new platelets as well as increases platelet aggregation. This is achieved by activating the thromboxane receptor, which results in platelet-shape change, inside-out activation of integrins, and degranulation. Circulating fibrinogen binds these receptors on adjacent platelets, further strengthening the clot. Thromboxane A2 is also a known vasoconstrictor and is especially important during tissue injury and inflammation. It is also regarded as responsible for Prinzmetal's angina.

Dame Anna Felicja Dominiczak DBE FRCP FRSE FAHA FMedSci is a Polish-born British medical researcher, Regius Professor of Medicine - the first woman to hold this position, and the Chief Scientist (Health) for the Scottish Government. From 2010 to 2020, Dominiczak was the Vice-Principal and Head of the College of Medical, Veterinary and Life Sciences at the University of Glasgow, Scotland. She is an Honorary Consultant Physician and Endocrinologist for the NHS Greater Glasgow and Clyde Health Board, and Health Innovation Champion for the Medical Research Council. From 2013 to 2015, Dominiczak was president of the European Society of Hypertension. She is the current Editor-in-Chief of Precision Medicine, a new journal launched in July 2023.

Donald Robert James Singer was a British clinical pharmacologist who was the president of the Fellowship of Postgraduate Medicine.

Orthostatic hypertension is a medical condition consisting of a sudden and abrupt increase in blood pressure (BP) when a person stands up. Orthostatic hypertension is diagnosed by a rise in systolic BP of 20 mmHg or more when standing. Orthostatic diastolic hypertension is a condition in which the diastolic BP raises to 98 mmHg or over in response to standing, but this definition currently lacks clear medical consensus, so is subject to change. Orthostatic hypertension involving the systolic BP is known as systolic orthostatic hypertension.

Roderick John Flower, also known as Rod, is a British pharmacologist, and professor at Barts and The London School of Medicine and Dentistry. Dr. Flower is a member of the board of directors of Antibe Therapeutics and on the scientific advisory board of Morria.

<span class="mw-page-title-main">Tilli Tansey</span>

Elizabeth Matilda Tansey is an Emerita Professor of the history of medicine and former neurochemist, best known for her role in the Wellcome Trust's witness seminars. She previously worked at Queen Mary University of London (QMUL).

Rohini Kuner is an Indian-born German pharmacologist and director of the Institute of Pharmacology at Heidelberg University.

Rhian M. Touyz Koppel MBBCh, MSc (Med), PhD, FRCP, FRSE, FMedSci, FCAHS is a Canadian medical researcher. She is currently serving as the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre in Montreal, Canada, since 2021. A clinician scientist, her research primarily focuses on hypertension and cardiovascular disease.

<span class="mw-page-title-main">David Webb (pharmacologist)</span>

David John Webb, is a British physician, scientist and clinical pharmacologist, who currently holds the Christison Chair of Therapeutics and Clinical Pharmacology at the University of Edinburgh.

Catherine Olufunke Falade is a professor of pharmacology and therapeutics and also the director of the Institute for Advanced Medical Research & Training at the College of Medicine at the University of Ibadan in Nigeria. She is also a healthcare practitioner specializing as a pharmacologist at the University College Hospital, Ibadan. Her research interest focuses on malaria in children. She collaborates with the Malaria Control Units of both the State and Federal Ministries of Health.

<span class="mw-page-title-main">Harriet P. Dustan</span> American physician

Harriet Pearson Dustan (1920–1999) was an American physician who is known for her pioneering contributions to effective detection and treatment of hypertension. She was the first woman to serve on the Board of Governors of the American Board of Internal Medicine.

Sir Mark Jonathan Caulfield MD, FRCP, FESC, FPharm, FBHS, FMedSci (born 19 July 1960) is a British genomic medicine researcher and Warden of Barts and The London School of Medicine and Dentistry. He is the Professor of Clinical Pharmacology at the William Harvey Research Institute in Queen Mary University of London. He was awarded a knighthood in the 2019 Birthday Honours.

Sussan Nourshargh is a British immunologist, pharmacologist, and professor of microvascular pharmacology and immunopharmacology. She founded the Centre for Microvascular research at Queen Mary University.

Sir Colin Terence Dollery was a clinical pharmacologist who spent much of his life working for SmithKline Beecham and its successor, Glaxo Smith Kline. He was knighted in the Queen's 1987 birthday honours. He was an honorary fellow of the British Pharmacological Society and a fellow of the Academy of Medical Sciences.

<span class="mw-page-title-main">Fiona Marshall (pharmacologist)</span> British pharmacologist

Fiona Hamilton Marshall is a British pharmacologist, founder and Senior Vice President of Discovery, Preclinical & Translational Medicine at Merck & Co. She will become the next president of the Novartis Institutes for BioMedical Research. She previously served as Chief Scientific Officer at Heptares Therapeutic, where she was Vice President of the Japanese biopharmaceutical company Sosei. She was elected Fellow of the Academy of Medical Sciences in 2016 and the Royal Society in 2021.

Louise Clare Kenny is a British physician who is Professor and Executive Pro-Vice-Chancellor at the University of Liverpool. She was elected an Commander of the Order of the British Empire in the 2022 New Year Honours.

Murielle Bochud is a Swiss physician. She is co-chief of the Department of Epidemiology and Health Systems at the University Centre for Primary Care and Public Health (Unisanté) in Lausanne. Her research considers the epidemiology of cardio-metabolic diseases and genetic epidemiology.

References

  1. 1 2 3 4 5 6 7 8 ""Sex and drugs: my rock and roll": Introducing the 2023 Paget Lecturer, Professor Amrita Ahluwalia". Understanding Animal Research. Retrieved 2023-12-21.
  2. 1 2 "Life as a Female Pharmacologist in Academia – Prof. Amrita Ahluwalia". WISE@QMUL. 2016-03-04. Retrieved 2023-12-21.
  3. ↑ "Investigations into the mechanisms of topical steroid anti-inflammatory action | WorldCat.org". search.worldcat.org. Retrieved 2023-12-20.
  4. ↑ "Ahluwalia, Amrita". www.qmul.ac.uk. Retrieved 2023-12-20.
  5. ↑ "Life as a Female Pharmacologist in Academia – Prof. Amrita Ahluwalia". WISE@QMUL. 2016-03-04. Retrieved 2023-12-20.
  6. ↑ Kapil, V.; Khambata, R. S.; Robertson, A.; Caulfield, M. J.; Ahluwalia, A. (2015-02-21). "Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: A randomized, phase 2, double-blind, placebo-controlled study". Hypertension. doi: 10.1161/HYPERTENSIONAHA.114.04675 . ISSN   0194-911X. PMC   4288952 .
  7. ↑ www.pageunderconstruction.co.uk. "Prof Amrita Ahluwalia". QMUL Centre for Predictive in vitro Models. Retrieved 2023-12-21.
  8. ↑ Professor Amrita Ahluwalia, GlaxoSmithKline Prize Lecture 2013 , retrieved 2023-12-21
  9. ↑ "Amrita Ahluwalia awarded Women in Science and Engineering prize". Queen Mary University of London. 2015-11-16. Retrieved 2023-12-21.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.